Cargando…
Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Grafted with Trastuzumab: A Proof-of-Concept Study in Prostate Cancer
Prostate cancer (PCa) is the second most common cancer in men worldwide and the fifth leading cause of death by cancer. The overexpression of TCTP protein plays an important role in castration resistance. Over the last decade, antisense technology has emerged as a rising strategy in oncology. Using...
Autores principales: | Sicard, Guillaume, Paris, Clément, Giacometti, Sarah, Rodallec, Anne, Ciccolini, Joseph, Rocchi, Palma, Fanciullino, Raphaëlle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761013/ https://www.ncbi.nlm.nih.gov/pubmed/33260460 http://dx.doi.org/10.3390/pharmaceutics12121166 |
Ejemplares similares
-
Docetaxel–trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer
por: Rodallec, Anne, et al.
Publicado: (2018) -
From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer
por: Rodallec, Anne, et al.
Publicado: (2018) -
Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept
por: Bitounis, Dimitrios, et al.
Publicado: (2012) -
Prototyping Trastuzumab Docetaxel Immunoliposomes with a New FCM-Based Method to Quantify Optimal Antibody Density on Nanoparticles
por: Rodallec, A., et al.
Publicado: (2020) -
Tumor growth monitoring in breast cancer xenografts: A good technique for a strong ethic
por: Rodallec, Anne, et al.
Publicado: (2022)